Ignite Creation Date:
2024-05-06 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03631407
Status:
COMPLETED
Last Update Posted:
2022-07-12
First Post:
2018-08-09
Brief Title:
Safety and Efficacy of Vicriviroc MK-7690 in Combination With Pembrolizumab MK-3475 in Participants With AdvancedMetastatic Microsatellite Stable MSS Colorectal Cancer CRC MK-7690-046
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Organization Data
Organization:
Merck Sharp Dohme LLC
Class:
INDUSTRY
Study ID:
7690-046
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None